USPTO serial 98589855
ENHANCESILK
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- GUTTADAURO, JULIE MARIE
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with ENHANCESILK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Jersey City, NJ, US
Jersey City, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay H. Kaplan
P.O. Box 4062Kingston, NY 12402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics, namely, beauty masks, cosmetic kits comprising primarily of lotions, creams, and preparations for skin care, cosmetic creams, lotions for cosmetic purposes, cosmetic lotions, cosmetic preparations for skin care, pomades for cosmetic purposes, tissues impregnated with cosmetic lotions, cotton buds for cosmetic purposes, cosmetic kits for skin care comprising primarily of lotions, creams, and preparations for skin care, non-medicated preparations for skin care, namely, skin serum not for medical use, skin care preparations, namely, non-medicated skin serum, non-medicated stimulating lotions for the skin, anti-wrinkle cream for skin care, non-medicated anti-aging serum; non-medicated hyaluronic acid skin care preparations; non-medicated silk skin care preparations; socks impregnated with moisturizing preparations for the feet; facial sheet mask impregnated with moisturizing preparations for the face; eye mask impregnated with moisturizing preparations for the eye area. | ACTIVE | — |
| 005 | Injectable hyaluronic acid for aesthetic treatments; injectable silk proteins, namely silk fibroin and sericin, for aesthetic treatments; injectable platelet rich plasma for aesthetic treatments; injectable platelet rich fibrin for aesthetic treatments; biological preparations for medical use, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, stem cells, hyaluronic acid, chitosan, silk fibroin, and silk sericin, or any combinations thereof; pharmaceutical preparations, namely, solutions for application on skin tissue for the purpose of promoting cellular regeneration; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions for the treatment of damaged skin and tissue; medicated skin care preparations; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; preparations for medical purposes for cleaning the skin; cells for medical or clinical purposes; such goods not including implantable medical devices for use in the regeneration of natural tissue. | ACTIVE | — |
| 010 | Medical devices, namely, kits containing blood collection tubes, drug administration tubes, glass vials, injection syringes, needles for medical use, needle holders, separator gels, blood transfer devices, anticoagulant reagents, injectable hyaluronic acid, silk-based wound treatment materials, and chitosan-based wound treatment materials, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, and platelet rich fibrin; medical apparatus and instruments for use in cosmetics, esthetics, facial, face-lift and plastic surgery; syringes for injections; receptacles for applying medicines, namely, bottles, jars, containers, canuale, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; medical injection instruments; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; medical apparatus used for taking blood; apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 8, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 8, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 8, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 2, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 2, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 2, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 9, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 15, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 15, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2025 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 14, 2025 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 23, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 7, 2024 | NWAP | NEW APPLICATION ENTERED | — |